Organogenesis Expands Biomanufacturing at Davis Companies' Facility
Deal News | May 30, 2025 | Davis Cos/The
The Davis Companies has announced a significant lease agreement with Organogenesis Holdings Inc. for a 123,000-square foot biomanufacturing facility at 100 Technology Way, Smithfield, Rhode Island. This move is meant to bolster Organogenesis' production capabilities in regenerative medicine, targeting markets like Advanced Wound Care and Surgical & Sports Medicine. Davis Companies views this as an opportunity to reinforce its role in facilitating innovation and scaling operations for top-tier clients. With a strategic location, close to Cambridge and Boston, the facility is well-positioned to serve New England’s life science community. The multi-year project will enhance the facility’s cGMP capabilities, underscoring Organogenesis' commitment to the New England economy. Representation during the transaction was managed by JLL for Organogenesis and Newmark for Davis Companies.
Sectors
- Biomanufacturing
- Life Sciences
- Real Estate
Geography
- United States – The country where the activities and companies in the article are based.
- Rhode Island – The specific state where the facility at 100 Technology Way is located.
- New England – The broader region benefiting from economic and innovative input due to the expansion.
Industry
- Biomanufacturing – The industry deals with the production of biologically-based products, significant to the article as Organogenesis is expanding in this sector.
- Life Sciences – Focuses on the study of living organisms which is relevant through Organogenesis' commitment to advancing regenerative medicine.
- Real Estate – Concerns the leasing of property as Davis Companies provides facilities to biomanufacturing clients like Organogenesis.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| The Davis Companies | Property Lessor | Company | A real estate investment firm providing biomanufacturing facilities. |
| Organogenesis Holdings Inc. | Tenant | Company | A leading regenerative medicine company expanding its manufacturing capabilities. |
| JLL | Tenant Representation | Company | Represented Organogenesis in the lease agreement. |
| Newmark | Lessor Representation | Company | Represented Davis Companies in the lease agreement. |